Patient’s own cells ‘can be reprogrammed to correct genetic defects’April 5th, 2011 - 6:39 pm ICT by ANI
Washington, April 5 (ANI): Scientists from the Morgridge Institute for Research, the University of Wisconsin-Madison, the University of California and the WiCell Research Institute are one step closer to treating individuals with genetic disorders using their own reprogrammed and corrected cells.
The finding carries potential applications in gene therapy treatments for Huntington’s disease, degenerative retinal disease or diabetes.
The researchers found that the process of correcting a genetic defect does not substantially increase the number of potentially cancer-causing mutations in induced pluripotent stem cells.
Their work suggested that human induced pluripotent stem cells altered to correct a genetic defect might be cultured into subsequent generations of cells that remain free of the initial disease.
However, although the gene correction itself does not increase the instability or the number of observed mutations in the cells, the study reinforced other recent findings that induced pluripotent stem cells themselves carry a significant number of genetic mutations.
“This study showed that the process of gene correction is compatible with therapeutic use,” said Sara Howden, primary author of the study, who serves as a postdoctoral research associate in James Thomson’s lab at the Morgridge Institute for Research.
“It also was the first to demonstrate that correction of a defective gene in patient-derived cells via homologous recombination is possible,” she said.
In the study, the researchers used a technique called episomal reprogramming to generate the induced pluripotent stem cells.
The technique allowed them to produce cells that were free of potentially harmful transgene sequences.
The scientists then corrected the actual retinal disease-causing gene defect using a technique called homologous recombination.
The stem cells were extensively “characterized” or studied before and after the process to assess whether they developed significant additional mutations or variations.
The results showed that the culture conditions required to correct a genetic defect did not substantially increase the number of mutations.
“By showing that the process of correcting a genetic defect in patient-derived induced pluripotent cells is compatible with therapeutic use, we eliminated one barrier to gene therapy based on these cells,” said Howden.
The study is published in the online edition of the journal Proceedings of the National Academy of Sciences. (ANI)
- Easy to manipulate human stem cell developed - Jun 09, 2010
- Skin cells used to develop heart defect 'treatment' in first-of-its-kind - Feb 10, 2011
- Turning diseased blood cells to stem cells may reveal cancer quickly - Feb 05, 2011
- Scientists generate pluripotent stem cells from horses - Feb 28, 2011
- Patients' own cells 'may shed light into schizophrenia causes' - Apr 14, 2011
- Scientists convert skin cells to stem cells more effieciently - Feb 03, 2011
- Scientists convert skin cells directly into beating heart cells - Feb 01, 2011
- Boffins 'reprogram' adult mouse fat cells into stem cells - Jul 27, 2010
- Stem cell therapy for age-related macular degeneration may soon be a reality - Mar 25, 2011
- Reprogrammed human blood cells could help in disease research - Jul 02, 2010
- Israeli scientists open prospect of repairing damaged hearts - May 23, 2012
- Scientists turn stem cells into intestinal tissue for the first time - Dec 13, 2010
- Marker indicating developmental potential of stem cells discovered - Apr 17, 2010
- Scientists develop new test for 'pluripotent' stem cells - Mar 07, 2011
- Stem cell breakthrough could offer cure for motor neurone disease - May 24, 2010
Tags: defective gene, gene defect, gene therapy treatments, generations, genetic defect, genetic defects, genetic disorders, genetic mutations, howden, huntington, james thomson, pluripotent stem cells, postdoctoral research associate, recombination, retinal disease, scientists, sequences, university of wisconsin, university of wisconsin madison, wicell research institute